Models of haematopoiesis: Seeing the wood for the trees

Nature Reviews Immunology

Volumn 9, Issue 4, 2009, Pages 293-300

  Ceredig, Rhodri ^a   Rolink, Antonius G ^b   Brown, Geoffrey ^c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 7 RECEPTOR ALPHA; RAG1 PROTEIN; RAG2 PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PAX5;

B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL SPECIFICITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOID CELL; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HEMATOPOIESIS; HUMANS; LYMPHOID PROGENITOR CELLS; MODELS, BIOLOGICAL; MYELOID PROGENITOR CELLS; PRECURSOR CELLS, B-LYMPHOID; PRECURSOR CELLS, T-LYMPHOID; TRANSCRIPTION FACTORS;

EID: 63149172079     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2525     Document Type: Note

References (80)

1. Till, J. E. & McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222 (1961).
2. Bradley, T. R. & Metcalf, D. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. Sci. 44, 287-299 (1966).
3. Dexter, T. M. Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol. 62, 299-305 (1979).
4. Whitlock, C. A. & Witte, O. N. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc. Natl Acad. Sci. USA 79, 3608-3612 (1982).
5. Bell, J. J. & Bhandoola, A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452, 764-767 (2008).
6. Wada, H. et al. Adult T-cell progenitors retain myeloid potential. Nature 452, 768-772 (2008).
7. Graf, T. Immunology: blood lines redrawn. Nature 452, 702-703 (2008).
8. Kondo, M., Weissman, I. L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672 (1997).
9. + lymphomyeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
10. - hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 35, 2019-2030 (2005).
11. Porritt, H. E. et al. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20, 735-745 (2004).
12. Sambandam, A. et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nature Immunol. 6, 663-670 (2005).
13. Benz, C. & Bleul, C. C. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J. Exp. Med. 202, 21-31 (2005).
14. Lehar, S. M., Dooley, J., Farr, A. G. & Bevan, M. J. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105, 1440-1447 (2005).
15. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197 (2000).
16. Taghon, T. N., David, E. S., Zúñiga-Pflücker, J. C. & Rothenberg, E. V. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965-978 (2005).
17. Katsura, Y. Redefinition of lymphoid progenitors. Nature Rev. Immunol. 2, 127-132 (2002).
18. + common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood 111, 5562-5570 (2008).
19. Serwold, T., Richie Ehrlich, L. I. & Weissman, I. L. Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. Blood 113, 807-815 (2009).
20. Nutt, S. L., Heavey, B., Rolink, A. G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556-562 (1999).
21. Rolink, A. G., Nutt, S. L., Melchers, F. & Busslinger, M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401, 603-606 (1999).
22. + multipotent hematopoietic progenitors. Cell 126, 415-426 (2006).
23. Rolink, A. G., Massa, S., Balciunaite, G. & Ceredig, R. Early lymphocyte development in bone marrow and thymus. Swiss Med. Wkly 136, 679-683 (2006).
24. Rolink, A. G., Balciunaite, G., Demoliere, C. & Ceredig, R. The potential involvement of Notch signaling in NK cell development. Immunol. Lett. 107, 50-57 (2006).
25. Ceredig, R., Rauch, M., Balciunaite, G. & Rolink, A. G. Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 108, 1216-1222 (2006).
26. Bosco, N., Ceredig, R. & Rolink, A. Transient decrease in interleukin-7 availability arrests B lymphopoiesis during pregnancy. Eur. J. Immunol. 38, 381-390 (2008).
27. Cobaleda, C., Schebesta, A., Delogu, A. & Busslinger, M. Pax5: the guardian of B cell identity and function. Nature Immunol. 8, 463-470 (2007).
28. Laurent, J., Bosco, N., Marche, P. N. & Ceredig, R. New insights into the proliferation and differentiation of early mouse thymocytes. Int. Immunol. 16, 1069-1080 (2004).
29. Godfrey, D. I. & Zlotnik, A. Control points in early T-cell development. Immunol. Today 14, 547-553 (1993).
30. Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nature Immunol. 4, 168-174 (2003).
31. Balciunaite, G., Ceredig, R. & Rolink, A. G. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood 105, 1930-1936 (2005).
32. Koch, U. et al. Simultaneous loss of β- and γ-catenin does not perturb hematopoiesis or lymphopoiesis. Blood 111, 160-164 (2008).
33. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
34. Zediak, V. P., Maillard, I. & Bhandoola, A. Closer to the source: notch and the nature of thymus-settling cells. Immunity 23, 245-248 (2005).
35. Ceredig, R., Bosco, N. & Rolink, A. G. The B lineage potential of thymus settling progenitors is critically dependent on mouse age. Eur. J. Immunol. 37, 830-837 (2007).
36. Weissman, I. L., Anderson, D. J. & Gage, F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17, 387-403 (2001).
37. Pang, L., Weiss, M. J. & Poncz, M. Megakaryocyte biology and related disorders. J. Clin. Invest. 115, 3332-3338 (2005).
38. Borzillo, G. V., Ashmun, R. A. & Sherr, C. J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell. Biol. 10, 2703-2714 (1990).
39. Boyd, A. W. & Schrader, J. W. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 297, 691-693 (1982).
40. Cumano, A., Paige, C. J., Iscove, N. N. & Brady, G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356, 612-615 (1992).
41. Fisher, A. G. et al. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential. Int. Immunol. 7, 415-423 (1995).
42. Montecino-Rodriguez, E., Leathers, H. & Dorshkind, K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nature Immunol. 2, 83-88 (2001).
43. Lai, A. Y. & Kondo, M. Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J. Exp. Med. 203, 1867-1873 (2006).
44. Ye, M. & Graf, T. Early decisions in lymphoid development. Curr. Opin. Immunol. 19, 123-128 (2007).
45. Warren, L. A. & Rothenberg, E. V. Regulatory coding of lymphoid lineage choice by hematopoietic transcription factors. Curr. Opin. Immunol. 15, 166-175 (2003).
46. Brown, G. et al. The sequential determination model of hematopoiesis. Trends Immunol. 28, 442-448 (2007).
47. Ishikawa, F. et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood 110, 3591-3660 (2007).
48. low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 109, 1460-1471 (2007).
49. Luc, S., Buza-Vidas, N. & Jacobsen, S. E. Delineating the cellular pathways of hematopoietic lineage commitment. Semin. Immunol. 20, 213-220 (2008).
50. Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nature Rev. Immunol. 7, 19-30 (2007).
51. Kawamoto, H. A close developmental relationship between the lymphoid and myeloid lineages. Trends Immunol. 27, 169-175 (2006).
52. Enver, T. & Greaves, M. Loops, lineage, and leukemia. Cell 94, 9-12 (1998).
53. Graf, T. Differentiation plasticity of hematopoietic cells. Blood 99, 3089-3101 (2002).
54. Pina, C. et al. MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2, 264-273 (2008).
55. Yang, L. V. et al. The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells. Leukemia 20, 417-425 (2006).
56. Metcalf, D. et al. Clonogenic mast cell progenitors and their excess numbers in chimeric BALB/c mice with inactivated GATA-1. Proc. Natl Acad. Sci. USA 104, 18642-18647 (2007).
57. Sugiyama, D. et al. Differential context-dependent effects of friend of GATA-1 (FOG-1) on mast-cell development and differentiation. Blood 111, 1924-1932 (2008).
58. Galloway, J. L. et al. Loss of Gata1 but not Gata2 converts erythropoiesis to myelopoiesis in zebrafish embryos. Dev. Cell 8, 109-116 (2005).
59. Laiosa, C. V., Stadtfeld, M. & Graf, T. Determinants of lymphoid-myeloid lineage diversification. Annu. Rev. Immunol. 24, 705-738 (2006).
60. Hamaguchi-Tsuru, E. et al. Development and functional analysis of eosinophils from murine embryonic stem cells. Br. J. Haematol. 124, 819-827 (2004).
61. Dahl, R. et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPα ratio and granulocyte colony-stimulating factor. Nature Immunol. 4, 1029-1036 (2003).
62. Bharadwaj, A. S. & Agrawal, D. K. Transcription factors in the control of dendritic cell life cycle. Immunol. Res. 37, 79-96 (2007).
63. Henkel, G. & Brown, M. A. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc. Natl Acad. Sci. USA 91, 7737-7741 (1994).
64. DeKoter, R. P. & Singh, H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288, 1439-1441 (2000).
65. Heath, V. et al. C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104, 1639-1647 (2004).
66. Zhang, P. et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21, 853-863 (2004).
67. Iwasaki, H. et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 20, 3010-3021 (2006).
68. Cantor, A. B. et al. Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J. Exp. Med. 205, 611-624 (2008).
69. Wang, D., D'Costa, J., Civin, C. I. & Friedman, A. D. C/EBPα directs monocytic commitment of primary myeloid progenitors. Blood 108, 1223-1229 (2006).
70. Mukai, H. Y. et al. Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation. Mol. Cell. Biol. 26, 7953-7965 (2006).
71. Cai, D. H. et al. C/EBPα:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBPα homodimers or AP-1. Oncogene 27, 2772-2779 (2008).
72. Buitenhuis, M. et al. Protein kinase B (C-AKT) regulates hematopoietic lineage choice decisions during myelopoiesis. Blood 111, 112-121 (2008).
73. Kamath, M. B. et al. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity. Leukemia 22, 1214-1225 (2008).
74. Friedman, A. D. Transcriptional control of granulocyte and monocyte development. Oncogene 26, 6816-6828 (2007).
75. Yang, L. et al. Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood 110, 3853-3861 (2007).
76. Li, C. Y. et al. Overexpression of a hematopoietic transcriptional regulator EDAG induces myelopoiesis and suppresses lymphopoiesis in transgenic mice. Leukemia 21, 2277-2286 (2007).
77. Rothenberg, E. V., Moore, J. E. & Yui, M. A. Launching the T-cell-lineage developmental programme. Nature Rev. Immunol. 8, 9-21 (2008).
78. Lohmann, F. & Bieker, J. J. Activation of Eklf expression during hematopoiesis by Gata2 and Smad5 prior to erythroid commitment. Development 135, 2071-2082 (2008).
79. Frontelo, P. et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood 110, 3871-3880 (2007).
80. Pongubala, J. M. et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nature Immunol. 9, 203-215 (2008).